Tech Company Financing Transactions
ImmuneWorks Funding Round
BioCrossroads participated in a $300 thousand funding round for ImmuneWorks. This venture round was announced on 10/31/2007.
Transaction Overview
Company Name
Announced On
10/31/2007
Transaction Type
Venture Equity
Amount
$300,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
351 West 10th St. 251
Indianapolis, IN 46202
USA
Indianapolis, IN 46202
USA
Phone
Website
Email Address
Overview
ImmuneWorks is an Indianapolis-based biotechnology company researching and developing treatments and therapies for autoimmune diseases of the lung such as idiopathic pulmonary fibrosis (IPF) and lung transplant rejections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wade Lang
Chief Scientific Officer
David Wilkes
VP - Operations
Kathia Rothhaar
VP - R & D
Michael Klemsz
VP - Regulatory Affairs
Tarrence Chew
Browse more venture capital transactions:
Prev: 10/31/2007: Tego venture capital transaction
Next: 11/1/2007: Novalar Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs